Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer

• Jesus Anampa,
• Tamanna Haque,
• Irina Murakhovskaya,
• Yanhua Wang,
• Kimo Bachiashvili,
• Cristian Papazoglu,
• Kith Pradhan,
• Ulrich G. Steidl,
• Joseph A. Sparano,
• Amit Verma

Affiliations

Jesus Anampa

Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center, NY, USA

Tamanna Haque

Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center, NY, USA

Irina Murakhovskaya

Department of Oncology, Division of Hematology, Montefiore Medical Center, NY, USA

Yanhua Wang

Department of Pathology, Montefiore Medical Center, NY, USA

Kimo Bachiashvili

Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center, NY, USA

Cristian Papazoglu

Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center, NY, USA

Kith Pradhan

Department of Developmental & Molecular Biology, NY, USA

Ulrich G. Steidl

Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA

Joseph A. Sparano

Department of Oncology, Section of Breast Medical Oncology, Montefiore Medical Center, NY, USA

Amit Verma

Department of Oncology, Division of Hematology, Montefiore Medical Center, NY, USA;Department of Developmental & Molecular Biology, NY, USA